Stakeholder group | Participant | Male | Higher hierarchical level |
---|---|---|---|
N (%) | N (%) | N (%) | |
Group 1 (macro level) | 24 (57) | 16 (63) | 18 (58) |
(i) Having direct relation to MDLC areas | 11 (46) | 5 (45) | 8 (73) |
CSG, MoH, General directorates | 4 (36) | 3 (75) | 4 (100) |
COFEPRIS, CENETEC | 6 (55) | 2 (33) | 3 (50) |
International organization or experts for Mexican health system | 1 (9) | 0 (0) | 1 (100) |
(ii) Indirect relation to MDLC areas | 13 (54) | 11 (85) | 10 (77) |
MoH, General directorates | 3 (23) | 2 (67) | 2 (67) |
National institutes, organizations, or experts concerned with public health, quality of health services, or patient safety | 8 (62) | 8 (100) | 6 (75) |
International organization or experts for Mexican health system | 2 (15) | 1 (50) | 2 (100) |
Group 2 (meso level)a | 5 (12) | 2 (40) | 4 (80) |
Financing/provision of health services | 3 (60) | 1 (33) | 3 (100) |
Quality of health services | 2 (40) | 1 (50) | 1 (50) |
Group 3 (micro level)a | 9 (21) | 7 (78) | 2 (22) |
Orthopaedic specialists | 9 (21) | 7 (78) | 2 (22) |
Group 4 (supplier) | 4 (10) | 3 (75) | 4 (100) |
Medical device industry association | 1 (25) | 0 (0) | 1 (100) |
Medical device supplier | 3 (75) | 3 (100) | 3 (100) |
Total | 42 (100) | 28 (67) | 28 (67) |